Obrazovanje kao komponenta karijernog vođenja i savetovanja u tranzicionim periodima profesionalnog razvoja odraslih
Objavio minche90 18. april 2024.
Naučni radovi, Skripte, Medicina
Objavio studenti.rs 18. septembar 2020. Prijavi dokument
Background: The aim of the study was to evaluate the bioequivalence of two itraconazole 100 mg capsule formulations.
Research design and methods: The single-center, open-label, randomized, three-period, three-sequence, reference-replicated, cross-over study included 38 healthy subjects under fed conditions. In each study period (separated by a 14-day washout), a single oral dose of the test (T) or reference (R) product was administered. Blood samples were collected at pre-dose and up to 72.0 h after administration. The calculated pharmacokinetic parameters, based on the plasma concentrations of itraconazole and hydroxy itraconazole, were AUC0-72h, AUC0-∝, Cmax, Tmax, T1/2 and Kel.
Results: The 90% CI for the test/reference geometric means ratio for the parent compound, itraconazole, was in the range from 85.29% to 116.07% for AUC0-72h. Since the coefficient of variation (CV) for the reference product was 44.95% for Cmax, the 90% CI for this parameter for itraconazole was 93.49-133.78%, which was within the proposed limits of the EMA for bioequivalence of 72.15-138.59%. During the study, 4 subjects encountered a total of 14 mild adverse events.
Objavio minche90 18. april 2024.
Objavio Wvv 05. decembar 2023.
Objavio milicab 02. oktobar 2023.
Objavio ghhjhghjghjgjh 18. april 2024.
Objavio ghhjhghjghjgjh 18. april 2024.
Objavio ghhjhghjghjgjh 18. april 2024.
Komentari
You must be logged in to post a comment.